Reaching 3 by 5…by 7: new report on universal access
30 August 2008. Related: Treatment access.
Treatment access
Oxfam criticises DFID’s new strategy as a “missed opportunity”
30 August 2008. Related: Treatment access.
Utility of routine viral load, CD4 count and clinical monitoring among HIV-positive adults in rural Uganda
12 June 2008. Related: Conference reports, Treatment access.
Implementation of more complex regimens for prevention of mother-to-child transmission of HIV in Rwanda
12 June 2008. Related: Conference reports, Treatment access.
The estimated cost of switching from d4T to TDF in South Africa
12 June 2008. Related: Conference reports, Treatment access.
Key patient safety concern removed in new FDA guidance for non-US trials
12 June 2008. Related: Treatment access.
FDA approval of generic ARVs
12 June 2008. Related: Treatment access.
New PMTCT guidelines for South Africa (Feb 2008)
1 April 2008. Related: Treatment access.
Boehringer fails to register tipranavir in Brazil after using Brazilian patients in registrational study
1 February 2008. Related: Antiretrovirals, Treatment access.
HIV and TB co-infection and treatment charges in the UK
1 December 2007. Related: Treatment access, TB coinfection.
Donor governments pledge record amounts to the Global Fund
2 October 2007. Related: Treatment access.
Survival of HIV-positive IDUs in the era of HAART
2 October 2007. Related: Treatment access.
Mbeki draws international scorn for firing deputy health minister
3 September 2007. Related: Treatment access.
Lesotho to revise national guidelines to include tenofovir first line
3 September 2007. Related: Treatment access.
International AIDS treatment advocacy group says overhaul needed to reach new G8 treatment goals
3 September 2007. Related: Treatment access.
Indian court ruling in Novartis case protects India as the pharmacy of the developing world
3 September 2007. Related: Treatment access.
Abbott drops lawsuit against community action
3 September 2007. Related: Treatment access.
G8 pledges to Africa are insufficient
3 July 2007. Related: Treatment access.
Abbott sues ACT-UP Paris
3 July 2007. Related: Treatment access.
UKs DFID support of Thailand
3 July 2007. Related: Treatment access.
Roche patent for hepatitis C drug challenged in India
3 July 2007. Related: Treatment access.
New PK data for protease inhibitors
4 May 2007. Related: Conference reports, Treatment access, Paediatric care, Guidelines.
Clinton Foundation announces significant price reductions for generic second-line drug and more tolerable first-line options
4 May 2007. Related: Treatment access.
Generic tenofovir licensed in South Africa
4 May 2007. Related: Treatment access.
Agreement for generic license of darunavir in South Africa
4 May 2007. Related: Treatment access.
Brazil issues plans to produce generic efavirenz
4 May 2007. Related: Treatment access.
Access to Abbott drugs in Thailand
4 May 2007. Related: Treatment access.
Indian government only plans to provide access to second-line ARVs after first-line drug treatment targets are met
4 May 2007. Related: Treatment access.
Increasing antiretroviral access for children
4 May 2007. Related: Treatment access, Paediatric care.
Abbott situation worsens in Thailand
4 April 2007. Related: Treatment access.
Wall Street Journal examines reason Abbott increased price of ritonavir
5 February 2007. Related: Treatment access.
Access to treatment in the USA: waiting list for ARVs in South Carolina
5 February 2007. Related: Treatment access.
Royalty-free license granted for development of tenofovir and topical microbicide
5 February 2007. Related: Treatment access, Vaccines and microbicides.
Novartis test case in India threatens the ARV pharmacy of the developing world
5 February 2007. Related: Treatment access.
Thailand issues compulsory license to manufacture lopinavir/r: WHO criticised for challenging this essential access to treatment
5 February 2007. Related: Treatment access.
Global Fund Board selects new executive director
5 February 2007. Related: Treatment access.
Clinton price for new paediatric treatment
6 December 2006. Related: Treatment access.
Indian generic heat-stable ritonavir
6 December 2006. Related: Treatment access.
Generic FDC of efavirenz/tenofovir/FTC launched by Cipla
6 December 2006. Related: Treatment access.
Compulsory license for efavirenz in Thailand
6 December 2006. Related: Treatment access.
Gilead licenses tenofovir to Indian generic manufacturers
7 October 2006. Related: Treatment access.
Funding prospects improve for Round 6 Global Fund
7 October 2006. Related: Treatment access.
Enough is enough: South African activists demand: fire Manto
10 September 2006. Related: Conference reports, Treatment access.
Treatment access: more optimistic results from scale up programmes
10 September 2006. Related: Conference reports, Treatment access.
Treatment access and community responses: online webcasts and debates
9 September 2006. Related: Conference reports, Treatment access.
Patent oppositions filed on three essential drugs
9 September 2006. Related: Treatment access.
Activists meet with Gilead and Abbott over access to second-line therapy
3 August 2006. Related: Treatment access.
Data exclusivity: a new threat to affordable generic medicines
3 August 2006. Related: Treatment access.
ITPC publish updated report on access to treatment
10 June 2006. Related: Treatment access.
Protesters evicted from UN headquarters, New York
10 June 2006. Related: Treatment access.
Community opposition filed against tenofovir patent application in India
10 June 2006. Related: Treatment access.
Lopinavir/r (meltrex) filed in South Africa
12 May 2006. Related: Treatment access.
Indian community organisations file first opposition against patent application
12 May 2006. Related: Treatment access.
ITPC Indian Mailbox database now online
12 May 2006. Related: Treatment access.
Global fund review: timing of Round 6 still unclear
12 May 2006. Related: Treatment access.
Treatment access new from Aidspan
9 April 2006. Related: Treatment access.
China puts 23 HIV/AIDS patients under house arrest
9 April 2006. Related: Treatment access.
TAC wins court case against Matthias Rath
26 March 2006. Related: Treatment access.
BMS licenses atazanavir to generic drug companies
7 March 2006. Related: Treatment access.
Missing the target: a report on HIV/AIDS treatment access from the frontlines
9 February 2006. Related: Treatment access.
New Clinton agreements to lower prices of HIV/AIDS rapid tests and second-line drugs in 50 countries
9 February 2006. Related: Treatment access.
WHO adds seven antiretrovirals to list of prequalified HIV drugs
9 February 2006. Related: Treatment access.
Ranbaxy launches two new ARVs in India
9 February 2006. Related: Treatment access.
FDA tentative approvals: generic oral solutions of nevirapine and d4T
9 February 2006. Related: Treatment access.
Amendment to WTO TRIPS agreement makes access to affordable medicines even more bleak: MSF expresses concern that patients the world-over will have to pay the price
9 February 2006. Related: Treatment access.